SLU-PP-322 is an experimental metabolic peptide developed to target one of the most elusive
problems in weight management:
the body's tendency to defend stored fat by slowing energy expenditure.
Rather than suppressing appetite or mimicking gut hormones, SLU-PP-322 is designed to act as a
metabolic switch, selectively increasing fat oxidation and energy dissipation at the cellular level-
particularly within adipose tissue.
SLU-PP-322 (5 Mg)
Traditional weight-loss strategies focus on:
- Eating less (appetite suppression)
- Moving more (behavioral expenditure)
SLU-PP-322 targets a third axis:
How efficiently the body converts stored fat into usable (and expendable) energy.
Its design philosophy is rooted in metabolic uncoupling without systemic toxicity, aiming to increase
calorie burn without stimulants, thyroid manipulation, or central nervous system stress.